Sign In
Buy COR
$306.28
-2.09 (-0.678%)
At Close: Aug 04, 2026
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Thursday, 27'th Mar 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
10:15am, Thursday, 27'th Mar 2025
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is Why Growth Investors Should Buy Cencora (COR) Now
01:46pm, Tuesday, 18'th Mar 2025
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
10:15am, Tuesday, 18'th Mar 2025
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, COR, JBL and KLAC hold promise.
VANCOUVER, BC / ACCESS Newswire / March 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (" Camino " or the " Company ") is pleased to provide an update on its previously announced 1
Here's Why You Should Add Cencora Stock to Your Portfolio Now
09:46am, Tuesday, 11'th Mar 2025
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Why Is Cencora (COR) Up 3.1% Since Last Earnings Report?
12:36pm, Friday, 07'th Mar 2025
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
09:20am, Friday, 28'th Feb 2025
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. SFM, COR and AXP are some stocks that hold promise.
3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR)
01:45pm, Thursday, 27'th Feb 2025
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
Cencora: Higher Potential Returns After Reduced Walgreens Stake
11:00am, Wednesday, 26'th Feb 2025
Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging population. The company has a strong economic moat, low leverage, BBB+ cred
Why Cencora (COR) is a Top Growth Stock for the Long-Term
10:45am, Friday, 21'st Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cencora (COR) is a Strong Value Stock
10:41am, Thursday, 20'th Feb 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 GARP Stocks That Investors Can Scoop Up for Maximum Returns
08:32am, Thursday, 13'th Feb 2025
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. AXP, COR and TPX hold promise.
Walgreens Sells Another Stake In Distributor Cencora For $300 Million
09:18pm, Thursday, 06'th Feb 2025
Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said Thursday
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
08:37pm, Thursday, 06'th Feb 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of ap
